Clinical Trial: Application of Chemotherapy Combined with Short-Course Radiotherapy and Toripalimab in Neoadjuvant Treatment of HR+/HER2- Breast Cancer: A Single-Center Prospective Randomized Controlled Study (China)

Posted On: 2026-10-30

China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of Chemotherapy Combined with Short-Course Radiotherapy and Toripalimab in Neoadjuvant Treatment of HR+/HER2- Breast Cancer: A Single-Center Prospective Randomized Controlled Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135543

Registration Time: 2026/10/30

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349684

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Application of Chemotherapy Combined with Short-Course Radiotherapy and Toripalimab in Neoadjuvant Treatment of HR+/HER2- Breast Cancer: A Single-Center Prospective Randomized Controlled Study (China)